The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2013Lung Tissue Model
Study Rationale:
Organovo will leverage its tools and expertise as a 3D biology company to construct a lung model suitable for the screening of certain pharmaceutical compounds. Robust lab-based lung... -
Research Grant, 2014Clinical and Neuroimaging Predictors of Cognitive Decline in Parkinson’s Disease
Objective/Rationale:
Parkinson’s disease (PD) dementia is often preceded by a phase of mild cognitive impairment (PD-MCI), for which diagnostic criteria have been recently proposed. However, there... -
Access to Data and Biospecimens, 2014CRP40 Expression as a Biomarker of Parkinson’s Disease
Objective/Rationale:
Alterations in HSPA9 gene expression has been described in Parkinson’s disease (PD). Ongoing studies suggest the expression of CRP40, a gene product of HSPA9, in the... -
Research Grant, 2013Evaluation of the RXR Agonist Compound IRX4204
Study Rationale:
Drugs that activate the retinoid X nuclear receptor (RXR) have been reported to promote survival of dopaminergic neurons in previously published pre-clinical studies. IRX4204 is a... -
Access to Data and Biospecimens, 2014Diffusion Tensor-based Biomarker for Parkinson's Disease
Objective/Rationale:
Magnetic resonance imaging (MRI) is a common tool used to diagnose or evaluate brain diseases such as Parkinson’s disease. Typically, MRI images are read by a... -
Rapid Response Innovation Awards, 2014Inhibition of Striatal-Enriched Phosphatase (STEP) to Improve Parkinson-Related Cognitive Dysfunction
Study Rationale:
As the enzyme striatal-enriched phosphatase (STEP) may be abnormally elevated in aged parkinsonian pre-clinical models with cognitive deficits, the possibility...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.